Horizon Therapeutics Public Ltd Co

NewEdge Advisors, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

800

Value ($000)

93

Weight

0.0%

2019 Q4 - 2023 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	93	0.0%	800	9/30/2023
2023 Q2	8/14/2023	129	0.0%	1,254	6/30/2023
2023 Q1	5/12/2023	114	0.0%	1,048	3/31/2023
2022 Q4	2/14/2023	56	0.0%	1,494	12/31/2022
2022 Q3	11/14/2022	434	0.0%	7,019	9/30/2022
2022 Q2	8/9/2022	632	0.0%	7,929	6/30/2022
2021 Q4	2/17/2022	899	0.0%	8,340	12/31/2021
2021 Q3	10/29/2021	1,189	0.0%	10,850	9/30/2021
2021 Q2	7/22/2021	976	0.0%	10,425	6/30/2021
2021 Q1	4/26/2021	382	0.0%	4,150	3/31/2021
2020 Q4	1/27/2021	301	0.0%	4,121	12/31/2020
2020 Q3	11/3/2020	276	0.0%	3,556	9/30/2020
2019 Q4	1/31/2020	298	0.0%	8,253	12/31/2019